Cephalon Sues Mylan, Sandoz Again Over Generic Fentora

Law360, New York (January 25, 2012, 8:11 PM EST) -- Cephalon Inc. sued Mylan Pharmaceuticals Inc. and Sandoz Inc. separately in Delaware federal court on Wednesday, alleging they infringed one of its patents when they applied for regulatory approval of generic versions of Cephalon's cancer pain therapy drug Fentora.

The patent-in-suit, which Cephalon acquired on Jan. 10, covers the oral delivery method and dosings of fentanyl citrate tablets. The company informed Sandoz and Mylan of its newly acquired patent on Tuesday, according to the suit.

Sandoz and Mylan previously filed abbreviated new drug applications for fentanyl...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.